These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 12440481)
1. Intraneuronal Abeta42 accumulation in Down syndrome brain. Mori C; Spooner ET; Wisniewsk KE; Wisniewski TM; Yamaguch H; Saido TC; Tolan DR; Selkoe DJ; Lemere CA Amyloid; 2002 Jun; 9(2):88-102. PubMed ID: 12440481 [TBL] [Abstract][Full Text] [Related]
2. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation. Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910 [TBL] [Abstract][Full Text] [Related]
3. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease. Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398 [TBL] [Abstract][Full Text] [Related]
4. Increased amyloid beta protein levels in children and adolescents with Down syndrome. Mehta PD; Capone G; Jewell A; Freedland RL J Neurol Sci; 2007 Mar; 254(1-2):22-7. PubMed ID: 17275850 [TBL] [Abstract][Full Text] [Related]
5. Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome. Cataldo AM; Petanceska S; Terio NB; Peterhoff CM; Durham R; Mercken M; Mehta PD; Buxbaum J; Haroutunian V; Nixon RA Neurobiol Aging; 2004; 25(10):1263-72. PubMed ID: 15465622 [TBL] [Abstract][Full Text] [Related]
6. Complement association with neurons and beta-amyloid deposition in the brains of aged individuals with Down Syndrome. Head E; Azizeh BY; Lott IT; Tenner AJ; Cotman CW; Cribbs DH Neurobiol Dis; 2001 Apr; 8(2):252-65. PubMed ID: 11300721 [TBL] [Abstract][Full Text] [Related]
7. Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury. Ikonomovic MD; Uryu K; Abrahamson EE; Ciallella JR; Trojanowski JQ; Lee VM; Clark RS; Marion DW; Wisniewski SR; DeKosky ST Exp Neurol; 2004 Nov; 190(1):192-203. PubMed ID: 15473992 [TBL] [Abstract][Full Text] [Related]
9. Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain. Boche D; Zotova E; Weller RO; Love S; Neal JW; Pickering RM; Wilkinson D; Holmes C; Nicoll JA Brain; 2008 Dec; 131(Pt 12):3299-310. PubMed ID: 18953056 [TBL] [Abstract][Full Text] [Related]
10. Active immunization trial in Abeta42-injected P301L tau transgenic mice. Kulic L; Kurosinski P; Chen F; Tracy J; Mohajeri MH; Li H; Nitsch RM; Götz J Neurobiol Dis; 2006 Apr; 22(1):50-6. PubMed ID: 16289870 [TBL] [Abstract][Full Text] [Related]
11. Early amyloid deposition in the medial temporal lobe of young Down syndrome patients: a regional quantitative analysis. Leverenz JB; Raskind MA Exp Neurol; 1998 Apr; 150(2):296-304. PubMed ID: 9527899 [TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner. Thal DR; Capetillo-Zarate E; Schultz C; Rüb U; Saido TC; Yamaguchi H; Haass C; Griffin WS; Del Tredici K; Braak H; Ghebremedhin E Acta Neuropathol; 2005 Nov; 110(5):459-71. PubMed ID: 16195918 [TBL] [Abstract][Full Text] [Related]
13. Amino-terminal modification and tyrosine phosphorylation of [corrected] carboxy-terminal fragments of the amyloid precursor protein in Alzheimer's disease and Down's syndrome brain. Russo C; Salis S; Dolcini V; Venezia V; Song XH; Teller JK; Schettini G Neurobiol Dis; 2001 Feb; 8(1):173-80. PubMed ID: 11162251 [TBL] [Abstract][Full Text] [Related]
14. Temporal accrual of complement proteins in amyloid plaques in Down's syndrome with Alzheimer's disease. Stoltzner SE; Grenfell TJ; Mori C; Wisniewski KE; Wisniewski TM; Selkoe DJ; Lemere CA Am J Pathol; 2000 Feb; 156(2):489-99. PubMed ID: 10666378 [TBL] [Abstract][Full Text] [Related]
15. Relationship between proteolytically cleaved gelsolin and levels of amyloid-β protein in the brains of Down syndrome subjects. Ji L; Chauhan V; Mehta P; Wegiel J; Mehta S; Chauhan A J Alzheimers Dis; 2010; 22(2):609-17. PubMed ID: 20847428 [TBL] [Abstract][Full Text] [Related]
16. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain. Güntert A; Döbeli H; Bohrmann B Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022 [TBL] [Abstract][Full Text] [Related]
17. Assessments of the accumulation severities of amyloid beta-protein and hyperphosphorylated tau in the medial temporal cortex of control and Alzheimer's brains. Zhou XW; Li X; Bjorkdahl C; Sjogren MJ; Alafuzoff I; Soininen H; Grundke-Iqbal I; Iqbal K; Winblad B; Pei JJ Neurobiol Dis; 2006 Jun; 22(3):657-68. PubMed ID: 16513361 [TBL] [Abstract][Full Text] [Related]
18. Abeta42-carboxy-terminal-like immunoreactivity is associated with intracellular neurofibrillary tangles and pick bodies. Schwab C; McGeer PL Exp Neurol; 2000 Feb; 161(2):527-34. PubMed ID: 10686074 [TBL] [Abstract][Full Text] [Related]
19. Molecular dating of senile plaques in the brains of individuals with Down syndrome and in aged dogs. Azizeh BY; Head E; Ibrahim MA; Torp R; Tenner AJ; Kim RC; Lott IT; Cotman CW Exp Neurol; 2000 May; 163(1):111-22. PubMed ID: 10785449 [TBL] [Abstract][Full Text] [Related]